Tag Archives: BIOTECH

“Time to Call out the Anti-GMO Conspiracy Theory”

Mark Lynas

In a speech last week at Cornell University on anti-GMO conspiracy theory, Mark Lynas told audiences “millions, possibly billions, of people have come to believe what is essentially a conspiracy theory, generating fear and misunderstanding about a whole class of technologies on an unprecedentedly global scale.” Formerly a devout anti-GMO activist himself, Lynas said his activism, “which I wrongly thought of at the time as being ‘environmental’, has done real damage in the world… I Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Debunking Ag Biotech’s Top 5 Myths

Book

On Reason.com, award-winning science correspondent Ronald Bailey takes on the Institute for Responsible Technology (IRT), an organization opposed to crop biotechnology. IRT published a list of reasons to avoid GMOs. Bailey says, “it’s a mish-mash of misinformation and disinformation. All of the institute’s assertions are unfounded.” In a detailed article chock full of scientific cites, Bailey debunks the following IRT Myths: 1. “GMOs Are Unhealthy” 2. “GMOs Increase Herbicide Use” 3. “Genetic Engineering Creates Dangerous Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,

A Bright Future for Orphan Disease Indications

Chart

In celebration of National Rare Disease Day BIO’s Industry Analysis team took a look at recently-approved drugs in the BioMedTracker database with an orphan indication designation. Our research found that 2012 saw the greatest number of approvals of therapies for orphan indications going back all the way to 2000 (This count includes previously approved drugs with new, orphan indication approvals).   Overall, 24 therapies were approved in orphan indications last year, including drugs for Anthrax, Gaucher’s Read More >

Inside BIO Industry Analysis  |  2 Comments  |  Email This Post
Tags: , , , , , , , , ,

Putting a Ring on It: Advice on Successful Drug Development Collaborations

Ring

Drug development partnerships can look lucrative to small biotechs eager to monetize their discoveries, but, like any relationship, these tie-ups take work and both parties run the risk of ending up in tears. At BIO’s recent CEO & Investor Conference, a panel of industry veterans gathered to discuss best practices in drug development partnering. Moderated by Jeff Stewart, Senior Engagement Manager with Campbell Alliance, the panel “Putting a Ring on it: When Drug Development Partnerships Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Thoughts on the President’s State of the Union

Jim Greenwood

I had several thoughts watching President Obama’s State of the Union Address tonight. First, we at BIO remain concerned about the possible impact that sequestration may have – specifically the potential impact it may have on human health. There are millions of patients – all hopeful that new treatments will become available soon. Our fear is that sequestration may impact the ability of those patients to access new treatments in a timely manner. That fear Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,